Pregled bibliografske jedinice broj: 901786
The impact of KIR2DS4 gene on clinical outcome after HSCT
The impact of KIR2DS4 gene on clinical outcome after HSCT // Tissue Antigens
Oxford: John Wiley & Sons, 2015. str. 388-388 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 901786 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The impact of KIR2DS4 gene on clinical outcome after HSCT
Autori
Burek Kamenaric, Marija ; Grubic, Zorana ; Stingl Jankovic, Katarina ; Maskalan, Marija ; Zunec, Renata
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Tissue Antigens
/ - Oxford : John Wiley & Sons, 2015, 388-388
Skup
The 29th European Immunogenetics and Histocompatibility Conference 2015
Mjesto i datum
Ženeva, Švicarska, 26.04.2015. - 29.04.2015
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
KIR2DS4 gene, HSCT
Sažetak
The aim of this research is to detect the frequencies of KIR2DS4 alleles in patients underwent related and unrelated haematopoietic stem cell transplantation (HSCT) and to study the impact of KR2DS4 alleles on clinical outcomes. Our findings suggested that the expression of full-length KIR2DS4 allele variants may contribute to a worse clinical outcome after HSCT and that KIR typing for KIR2DS4 would be beneficial for selecting suitable donors.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Zagreb
Profili:
Renata Žunec
(autor)
Marija Burek Kamenarić
(autor)
Marija Maskalan
(autor)
Katarina Štingl Janković
(autor)
Zorana Grubić
(autor)
